Govt announces ₹10 crore prize to develop new Sickle Cell Disease drug
Jun 19, 2025


Source: Economic Times
Share:
In a landmark push to eradicate sickle cell disease a life-threatening genetic disorder disproportionately affecting India’s tribal communities the government has announced a ₹10 crore prize for developing a new drug to treat the disease.
Key highlights:
Massive incentive for innovation
Union Minister of State for Tribal Affairs, Durgadas Uikey, launched the Bhagwan Birsa Munda Prize to reward innovators who develop a novel treatment for sickle cell disease.
The winning proposal will receive up to ₹10 crore in funding, overseen jointly by the Ministry of Tribal Affairs and AIIMS Delhi.
A nationwide mission
This announcement follows PM Modi’s launch of the National Sickle Cell Anaemia Eradication Mission on 1 July 2023, aiming to eliminate the disease by 2047.
The initiative targets screening 7 crore people under 40 years as part of early detection and intervention efforts.
Current treatment gaps
At present, only one drug exists for managing sickle cell disease.
Patients have no alternative options tailored to different medical profiles especially problematic in pregnancy or comorbidities.
The lack of therapeutic diversity is seen as a critical gap in treatment.
Tribal health research hub at AIIMS
The government also plans to set up a Centre for Tribal Health and Research Institute under AIIMS Delhi.
This Centre will include:
Inpatient and outpatient care
Specialist referrals from tribal areas
Policy research and guidance
New course in tribal medicine
A postgraduate course in tribal medicine will be introduced to train doctors in culturally contextualised public health and clinical skills for tribal regions.
This move is aimed at closing long-standing health inequities among India’s tribal populations.
With the announcement of this prize and the establishment of specialized tribal health infrastructure, India is taking a targeted, long-term approach to eliminate sickle cell disease. The initiative blends innovation, education, and policy reform, setting a precedent for health equity and indigenous healthcare reform.
Copyright © 2024 Pharmacy Pro. All rights reserved
Copyright © 2024 Pharmacy Pro. All rights reserved
Copyright © 2024 Pharmacy Pro. All rights reserved


Source: Economic Times
In a landmark push to eradicate sickle cell disease a life-threatening genetic disorder disproportionately affecting India’s tribal communities the government has announced a ₹10 crore prize for developing a new drug to treat the disease.
Key highlights:
Massive incentive for innovation
Union Minister of State for Tribal Affairs, Durgadas Uikey, launched the Bhagwan Birsa Munda Prize to reward innovators who develop a novel treatment for sickle cell disease.
The winning proposal will receive up to ₹10 crore in funding, overseen jointly by the Ministry of Tribal Affairs and AIIMS Delhi.
A nationwide mission
This announcement follows PM Modi’s launch of the National Sickle Cell Anaemia Eradication Mission on 1 July 2023, aiming to eliminate the disease by 2047.
The initiative targets screening 7 crore people under 40 years as part of early detection and intervention efforts.
Current treatment gaps
At present, only one drug exists for managing sickle cell disease.
Patients have no alternative options tailored to different medical profiles especially problematic in pregnancy or comorbidities.
The lack of therapeutic diversity is seen as a critical gap in treatment.
Tribal health research hub at AIIMS
The government also plans to set up a Centre for Tribal Health and Research Institute under AIIMS Delhi.
This Centre will include:
Inpatient and outpatient care
Specialist referrals from tribal areas
Policy research and guidance
New course in tribal medicine
A postgraduate course in tribal medicine will be introduced to train doctors in culturally contextualised public health and clinical skills for tribal regions.
This move is aimed at closing long-standing health inequities among India’s tribal populations.
With the announcement of this prize and the establishment of specialized tribal health infrastructure, India is taking a targeted, long-term approach to eliminate sickle cell disease. The initiative blends innovation, education, and policy reform, setting a precedent for health equity and indigenous healthcare reform.
Share:
Read Next
Read Next
Copyright © 2024 Pharmacy Pro. All rights reserved
Copyright © 2024 Pharmacy Pro. All rights reserved